Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exact permutational tests for group sequential clinical trials

C R Mehta1, N Patel, P Senchaudhuri

  • 1Department of Biostatistics, Harvard School of Public Health, Cambridge, Massachusetts.

Biometrics
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Droplet size distribution characteristics of Bacillus thuringiensis and Beauveria bassiana bio-pesticide solutions for hydraulic nozzles.

Scientific reports·2026
Same author

Analyzing Audiometric Data of Agricultural Tractor Drivers in India Using Data Mining Techniques.

Journal of agromedicine·2026
Same author

Optimization of specific spray volume for spray application in pomegranate orchard using response surface methodology.

Scientific reports·2026
Same author

Approach for ergonomic assessment of self-propelled combine harvester seats based on anthropometric body dimensions.

International journal of occupational safety and ergonomics : JOSE·2022
Same author

An adaptive population enrichment phase III trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma (TAPPAS trial).

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

A proposal for integrated efficacy-to-effectiveness (E2E) clinical trials.

Clinical pharmacology and therapeutics·2013
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

This study introduces an efficient algorithm for calculating stopping boundaries in group sequential clinical trials. It ensures accurate boundary generation even with limited early-stage data, improving trial analysis.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Computing

Background:

  • Group sequential methods are crucial for interim analyses in clinical trials.
  • Accurate stopping boundaries are essential for ethical and efficient trial conduct.
  • Existing methods may lack reliability with limited early-stage data.

Purpose of the Study:

  • To develop an efficient numerical algorithm for computing precise stopping boundaries in group sequential clinical trials.
  • To provide a method that is reliable even with limited data in early trial stages.
  • To derive stopping boundaries from the exact joint permutational distribution of linear rank statistics.

Main Methods:

  • The algorithm computes the exact boundary generating function using the joint permutational distribution.

Related Experiment Videos

  • Ranks are assigned after pooling all patients, with permutations within newly arrived blocks.
  • The method accommodates continuous/categorical, censored/uncensored data, and adaptive randomization.

    • Main Results:

    • The algorithm yields exact stopping boundaries, improving reliability in early trial phases.
    • It is applicable for an arbitrary number of monitoring times, adaptable to study needs.
    • Demonstrated utility through a group sequential analysis of an Eastern Cooperative Oncology Group study.

    Conclusions:

    • The developed algorithm offers an efficient and accurate approach to determining stopping boundaries for group sequential trials.
    • This method enhances the reliability of interim analyses, particularly when data is scarce.
    • The technique is versatile, supporting various data types and adaptive randomization strategies.